HCPCS ‘P’ Modifiers (17)

Modifier Description P1 A normal healthy patient P2 A patient with mild systemic disease P3 A patient with severe systemic disease P4 A patient with severe systemic disease that is a constant threat to life P5 A moribund patient who is not expected to survive without the operation P6 A declared brain-dead patient whose organs … Read more

HCPCS ‘N’ Modifiers (6)

Modifier Description N1 Group 1 oxygen coverage criteria met N2 Group 2 oxygen coverage criteria met N3 Group 3 oxygen coverage criteria met NB Nebulizer system, any type, fda-cleared for use with specific drug NR New when rented (use the ‘nr’ modifier when dme which was new at the time of rental is subsequently purchased) … Read more

HCPCS ‘M’ Modifiers (10)

Modifier Description M2 Medicare secondary payer (msp) MA Ordering professional is not required to consult a clinical decision support mechanism due to service being rendered to a patient with a suspected or confirmed emergency medical condition MB Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception … Read more

HCPCS ‘L’ Modifiers (9)

Modifier Description L1 Provider attestation that the hospital laboratory test(s) is not packaged under the hospital oppsTerminated December 31, 2016. LC Left circumflex coronary artery LD Left anterior descending coronary artery LL Lease/rental (use the ‘ll’ modifier when dme equipment rental is to be applied against the purchase price) LM Left main coronary artery LR … Read more

HCPCS ‘K’ Modifiers (31)

Modifier Description K0 Lower extremity prosthesis functional level 0 – does not have the ability or potential to ambulate or transfer safely with or without assistance and a prosthesis does not enhance their quality of life or mobility. K1 Lower extremity prosthesis functional level 1 – has the ability or potential to use a prosthesis … Read more

HCPCS ‘J’ Modifiers (16)

Modifier Description J1 Competitive acquisition program no-pay submission for a prescription number J2 Competitive acquisition program, restocking of emergency drugs after emergency administration J3 Competitive acquisition program (cap), drug not available through cap as written, reimbursed under average sales price methodology J4 Dmepos item subject to dmepos competitive bidding program that is furnished by a … Read more

HCPCS ‘H’ Modifiers (27)

Modifier Description H9 Court-ordered HA Child/adolescent program HB Adult program, non geriatric HC Adult program, geriatric HD Pregnant/parenting women’s program HE Mental health program HF Substance abuse program HG Opioid addiction treatment program HH Integrated mental health/substance abuse program HI Integrated mental health and intellectual disability/developmental disabilities program HJ Employee assistance program HK Specialized mental … Read more

HCPCS ‘G’ Modifiers (35)

Modifier Description G0 Telehealth services for diagnosis, evaluation, or treatment, of symptoms of an acute stroke G1 Most recent urr reading of less than 60 G2 Most recent urr reading of 60 to 64.9 G3 Most recent urr reading of 65 to 69.9 G4 Most recent urr reading of 70 to 74.9 G5 Most recent … Read more

HCPCS ‘F’ Modifiers (19)

Modifier Description F1 Left hand, second digit F2 Left hand, third digit F3 Left hand, fourth digit F4 Left hand, fifth digit F5 Right hand, thumb F6 Right hand, second digit F7 Right hand, third digit F8 Right hand, fourth digit F9 Right hand, fifth digit FA Left hand, thumb FB Item provided without cost … Read more

HCPCS ‘E’ Modifiers (16)

Modifier Description E1 Upper left, eyelid E2 Lower left, eyelid E3 Upper right, eyelid E4 Lower right, eyelid EA Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer chemotherapy EB Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy EC Erythropoetic stimulating agent (esa) administered to treat anemia not due … Read more

error: Content is protected !!